Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study.

Ann Rheum Dis 2012 Sep 4;71(9):1502-9. Epub 2012 Apr 4.

Division of Rheumatology, Nova Scotia Rehabilitation Centre (2nd Floor), 1341 Summer Street, Halifax, Nova Scotia B3H 4K4, Canada.

Objective: The aim of this study was to describe the frequency, attribution, outcome and predictors of seizures in systemic lupus erythematosus (SLE).

Methods: The Systemic Lupus International Collaborating Clinics, or SLICC, performed a prospective inception cohort study. Demographic variables, global SLE disease activity (SLE Disease Activity Index 2000), cumulative organ damage (SLICC/American College of Rheumatology Damage Index (SDI)) and neuropsychiatric events were recorded at enrolment and annually. Lupus anticoagulant, anticardiolipin, anti-β(2) glycoprotein-I, antiribosomal P and anti-NR2 glutamate receptor antibodies were measured at enrolment. Physician outcomes of seizures were recorded. Patient outcomes were derived from the SF-36 (36-Item Short Form Health Survey) mental component summary and physical component summary scores. Statistical analyses included Cox and linear regressions.

Results: The cohort was 89.4% female with a mean follow-up of 3.5±2.9 years. Of 1631 patients, 75 (4.6%) had ≥1 seizure, the majority around the time of SLE diagnosis. Multivariate analysis indicated a higher risk of seizures with African race/ethnicity (HR (CI): 1.97 (1.07 to 3.63); p=0.03) and lower education status (1.97 (1.21 to 3.19); p<0.01). Higher damage scores (without neuropsychiatric variables) were associated with an increased risk of subsequent seizures (SDI=1:3.93 (1.46 to 10.55); SDI=2 or 3:1.57 (0.32 to 7.65); SDI≥4:7.86 (0.89 to 69.06); p=0.03). There was an association with disease activity but not with autoantibodies. Seizures attributed to SLE frequently resolved (59/78 (76%)) in the absence of antiseizure drugs. There was no significant impact on the mental component summary or physical component summary scores. Antimalarial drugs in the absence of immunosuppressive agents were associated with reduced seizure risk (0.07 (0.01 to 0.66); p=0.03).

Conclusion: Seizures occurred close to SLE diagnosis, in patients with African race/ethnicity, lower educational status and cumulative organ damage. Most seizures resolved without a negative impact on health-related quality of life. Antimalarial drugs were associated with a protective effect.

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2011-201089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656036PMC
September 2012
99 Reads

Publication Analysis

Top Keywords

systemic lupus
12
lupus erythematosus
8
cohort study
8
inception cohort
8
component summary
8
prospective inception
8
disease activity
8
sle disease
8
antiribosomal anti-nr2
4
analysis indicated
4
multivariate analysis
4
glycoprotein-i antiribosomal
4
anti-β2 glycoprotein-i
4
diagnosis multivariate
4
enrolment physician
4
physician outcomes
4
outcomes seizures
4
sle diagnosis
4
measured enrolment
4
glutamate receptor
4

Similar Publications